Immunocore Holdings (IMCR) Earnings Date & Reports
Immunocore Holdings PLC is a commercial-stage biotechnology company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
IMCR is expected to report earnings to fall ∞% to -22 cents per share on March 04
Q4'25
Est.
$-0.22
Q3'25
Beat
by $0.24
Q2'25
Missed
by $0.02
Q1'25
Beat
by $0.49
Q4'24
Missed
by $0.23
The last earnings report on November 06 showed earnings per share of 0 cents, beating the estimate of -23 cents. With 956.00 shares outstanding, the current market capitalization sits at 1.79B.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. IMCR showed earnings on November 06, 2025. You can read more about the earnings report here.